(Total Views: 556)
Posted On: 08/20/2020 6:36:22 AM
Post# of 153875
From SA:
CytoDyn on go with UK late-stage study of leronlimab for COVID-19
Aug. 20, 2020 6:30 AM ET|About: CytoDyn Inc. (CYDY)|By: Douglas W. House, SA News Editor
The UK's Medicines and Healthcare products Regulatory Agency has signed off on a Phase 3 clinical trial evaluating CytDyn's (OTCQB:CYDY) leronlimab in severely and critically ill COVID-19 patients.
Yesterday, it requested Fast Track approval of the drug based on the results from a mid-stage study.
CytoDyn on go with UK late-stage study of leronlimab for COVID-19
Aug. 20, 2020 6:30 AM ET|About: CytoDyn Inc. (CYDY)|By: Douglas W. House, SA News Editor
The UK's Medicines and Healthcare products Regulatory Agency has signed off on a Phase 3 clinical trial evaluating CytDyn's (OTCQB:CYDY) leronlimab in severely and critically ill COVID-19 patients.
Yesterday, it requested Fast Track approval of the drug based on the results from a mid-stage study.
(2)
(0)
